Royal Bank of Canada
KYMR icon

Royal Bank of Canada’s Kymera Therapeutics KYMR Stock Holding History

Royal Bank of Canada’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60K Sell
730
-1,533
-68% -$121K ﹤0.01% 5397
2025
Q4 		$176K Sell
2,263
-234,711
-99% -$15.8M ﹤0.01% 4852
2025
Q3 		$13.4M Buy
236,974
+80,721
+52% +$3.64M ﹤0.01% 1946
2025
Q2 		$6.82M Buy
156,253
+154,109
+7,188% +$5.31M ﹤0.01% 2322
2025
Q1 		$59K Sell
2,144
-2,234
-51% -$81.4K ﹤0.01% 5507
2024
Q4 		$176K Sell
4,378
-1,397
-24% -$63.1K ﹤0.01% 4921
2024
Q3 		$273K Buy
5,775
+1,591
+38% +$70.3K ﹤0.01% 4571
2024
Q2 		$125K Buy
4,184
+3,048
+268% +$106K ﹤0.01% 5129
2024
Q1 		$46K Sell
1,136
-10,718
-90% -$383K ﹤0.01% 5577
2023
Q4 		$302K Buy
11,854
+7,096
+149% +$127K ﹤0.01% 4723
2023
Q3 		$66K Buy
4,758
+1,985
+72% +$39.9K ﹤0.01% 5622
2023
Q2 		$64K Buy
2,773
+640
+30% +$18.3K ﹤0.01% 5650
2023
Q1 		$63K Sell
2,133
-3,302
-61% -$106K ﹤0.01% 5496
2022
Q4 		$136K Buy
5,435
+4,975
+1,082% +$133K ﹤0.01% 5220
2022
Q3 		$10K Buy
460
+247
+116% +$6.51K ﹤0.01% 6423
2022
Q2 		$4K Sell
213
-1,929
-90% -$45.1K ﹤0.01% 6729
2022
Q1 		$90K Sell
2,142
-5,573
-72% -$235K ﹤0.01% 5730
2021
Q4 		$490K Buy
7,715
+4,158
+117% +$242K ﹤0.01% 4470
2021
Q3 		$209K Sell
3,557
-1,540
-30% -$89.3K ﹤0.01% 5133
2021
Q2 		$247K Buy
5,097
+2,815
+123% +$122K ﹤0.01% 4889
2021
Q1 		$89K Buy
2,282
+2,122
+1,326% +$128K ﹤0.01% 5541
2020
Q4 		$10K Buy
+160
New +$7.8K ﹤0.01% 6374

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return